Abstract
Introduction: Kaposi’s sarcoma (MK) is most likely caused by human herpes virus type 8 (HHV-8) which develops particularly in individuals infected with HIV. This disease causes purplish or brownish tumors on the skin. Other organs can be affected, such as the mucous membranes, and the viscera. The goal of our study is to describe the epidemiological, clinical and therapeutic profile of this disease. Chemotherapy has big interest in Kaposi sarcoma.
Highlights
Kaposi’s sarcoma (MK) is most likely caused by human herpes virus type 8 (HHV-8) which develops in individuals infected with HIV
The median progression-free survival of Kaposi disease treated in our department is 12 months and the average global survival of the Kaposi sarcoma extends to 52.95% over a 20-month follow-up
In our department, we mostly found the classic form of Kaposi disease
Summary
Kaposi’s sarcoma (MK) is most likely caused by human herpes virus type 8 (HHV-8) which develops in individuals infected with HIV. This disease causes purplish or brownish tumors on the skin. Kaposi’s sarcoma is a tumor associated with infection with the human herpes virus 8 (HHV8) which develops in individuals infected with HIV. This disease causes the appearance of purplish or brownish tumors on the skin. KS includes four epidemiological forms: classic KS, endemic KS, iatrogenic KS developing in immunocompromised individuals after organ transplantation, for example, and AIDS-related Kaposi sarcoma or AIDS-KS. The prognosis is quite poor and depends on the location of the tumor, the immune system and the systemic symptoms
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
